DrugPatentWatch Database Preview
Mayne Pharma Inc Company Profile
What is the competitive landscape for MAYNE PHARMA INC, and what generic and branded alternatives to MAYNE PHARMA INC drugs are available?
MAYNE PHARMA INC has twenty approved drugs.
Summary for Mayne Pharma Inc
| US Patents: | 0 |
| Tradenames: | 18 |
| Ingredients: | 18 |
| NDAs: | 20 |
Drugs and US Patents for Mayne Pharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma Inc | HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE | hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 205658-001 | Nov 17, 2015 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mayne Pharma Inc | DOXYCYCLINE | doxycycline | CAPSULE;ORAL | 209396-003 | Sep 29, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mayne Pharma Inc | DOFETILIDE | dofetilide | CAPSULE;ORAL | 207058-002 | Jun 6, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mayne Pharma Inc | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | SOLUTION;ORAL | 204092-001 | Jun 5, 2014 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mayne Pharma Inc | MORPHINE SULFATE | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 205386-002 | Oct 28, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mayne Pharma Inc | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 090177-002 | Oct 20, 2008 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
